Click here to get in touch with the Profounda Team.
Toll Free: (800) 407-6810
Generic to Arestin Microspheres by Bausch Health (Orapharma) receives Competitive Generic Therapy Designation
October 2, 2018
DOG AND HUMANS GET GREAT RESULTS
October 22, 2017
Sales exceed $2 Million for first year of Profounda's Commercial Presence in the USA
December 31, 2016
Orphan drug status approval for Acanthamoeba Keratitis received by Profounda for Miltefosine
Profounda Inc. receives FDA orphan-drug designation for the Treatment of Primary Amebic Meningoencephalitis (PAM) with Miltefosine
December 16, 2016
CNN report on Survivor of Brain Eating Amoeba
September 12, 2016
Patient survives Brain Eating Amoeba
Profounda working with local Health Officials in fight to save patients life.
August 12, 2016